4Raju N,Sobieraj -Teaque M,Hirsh J,et al. Effect of as- pirin onmortality in the primary prevention of cardiovas- cular disease[J]. Am J Med,2011,124(7) :621 -629.
5Antithrombotic Trialists Collaboration. Collaborative meta - analysis of randomized trials ofantiplatelet therapy for- prevention ofdeath, myocardial infarction, and stroke in high risk patients[J]. BMJ,2002,324(7329) :71 -86.
6Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta - analysis of individual participant data from randomized trials [ J ]. Lancet, 2009, 373 (9678) : 1849 - 1860.
7Halkes PH, Gray LJ, Bath PM, et al. Dipyridamole plus aspirin versus aspirin alone in secondary preven- tion after TIA or stroke : a meta - analysis by risk [ J ]. J Neurol Neurosurg Psychiatry ,2008,79( 11 ) : 1218.
